CytoMed Therapeutics Limited Increase Decrease Through Share-based Payment Transactions
CytoMed Therapeutics Limited (GDTC) reported Increase Decrease Through Share-based Payment Transactions of SGD 691.09 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2026-03-31
| Period end | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|
| 2025-12-31 | 691.09K SGD 20-F · filed 2026-03-31 |